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Complete cDNAs encoding human mitochondrial
translational initiation factor 2 (IF-2m t ) have been ob-
tained from liver, heart, and fetal brain cDNA libraries.
These cDNAs have a long open reading frame 2181 resi-
dues in length encoding a protein of 727 amino acids.
Overall, human IF-2m t has 30-40% identity to the corre-
sponding prokaryotic factors. Surprisingly, it is no more
homologous to yeast IF.2m t than to the IF-2s from bac-
terial sources. The greatest region of conservation lies
in the G-domain of this factor with less conservation in
the COOH-terminal half of the protein and very little
homology near the amino terminus. The 5'-untranslated
leaders of the liver and heart cDNAs contain a number
of short open reading frames. These sequences may play
a role in the translational activity of the IF.2m t mRNA.
Northern analysis indicates that the IF-2m t gene is ex-
pressed in all tissues but that the level of expression
varies over a wide range.
The initiation of protein biosynthesis has been extensively
studied in prokaryotes and in the cytoplasm of eukaryotic cells
(1-5). During the initiation process, initiation factor 2 promotes
the binding of the initiator tRNA to the small subunit of the
ribosome in a GTP-dependent manner. Prokaryotic initiation
factor 2 (IF_2)1is a single polypeptide chain having a molecular
weight of 78,000-97,000. It promotes tMet-tRNA binding to 30
S ribosomal subunits in a mRNA-dependent reaction. Eukary-
otic cytoplasmic initiation factor 2 (eIF-2) is a trimeric protein
with a molecular weight of 145,000 (3). It is responsible for the
binding of Met-tRNA to 40 S subunits. This reaction is believed
to occur prior to the interaction of the subunit with mRNA (3).
The mechanism of translational initiation in animal mito-
chondria is not yet understood, but several studies suggest that
it will have a number of unique features (6-9). To date, only
one initiation factor has been identified in the animal mito-
chondrial system (10,11). This factor, which was purified from
bovine liver, is equivalent to prokaryotic IF-2 and has been
designated IF-2m t (11). It is a monomeric protein with a molec-
ular weight of 85,000. IF-2 rn t promotes the binding of tMet-
tRNA to animal mitochondrial ribosomes in a GTP- and
mRNA-dependent reaction.
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Genes encoding IF-2 have been cloned from several prokary-
otic microorganisms (12-15). The cDNA sequences encoding
the a, 13, and 'Y subunits of eIF-2 have also been recently
reported (16-18). Although IF-2rn t in yeast has not been puri-
fied or characterized, its gene has been cloned (19), The se-
quence of this factor suggests that it has significant homology
to bacterial IF-2 except near the amino terminus. In the pres-
ent study, we have cloned and characterized the cDNAs for
IF-2rn t from human liver, heart, and fetal brain.
EXPERIMENTAL PROCEDURES
Polymerase Chain Reaction-Highly conserved peptide sequences
found in the G-domains of prokaryotic and mitochondrial IF-2s served
as the basis for designing primers for cDNA synthesis and the polym-
erase chain reaction (PCR). The oligonucleotide primers used were as
follows: PlR, C(T/C)TGIAC(G/A)TCNCCNCC based on the sequence
GGDVQ(AN); P2F, GCGGATCCIGTIGTNACNAT(C/A)ATGGG de-
rived from the sequence PVVTIMG; PIF, GGAATTCCICAGGC(I1
C)GA(T/C)CCIGCN(T/C)T based on the sequence PQADPAL; and P2R,
GGAATTCCGTAGTCTTCGCA(I1C)AC(I1C)AC(G/A)TC(G/A)TA from
the sequence YDVVCEDY. Residues added to the primers to facilitate
restriction enzyme digestion during cloning are underlined. Residues
indicated in parentheses designate degenerate positions.
For the production of cDNA clones, 2 IJ-g of polyrAl" RNA from
human liver was reverse transcribed with Moloney murine leukemia
virus reverse transcriptase basically as described (20). 1 IJ-l of the
reaction mixture was used for the initial PCR, which was carried out
using primers PIF and PIR. A portion (2 "I) of the first PCR reaction
mixture was then amplified using the nested primers P2F and P2R.
PCR reactions were analyzed on 4% NuSieve-agarose gels, and the
products were purified from the gel using silicon powder (Sigma) (21).
DNA fragments were digested with BamHI and EcoRI and cloned into
pTZ19R (Pharmacia Biotech Inc.) (22) The plasmid containing the
cloned portion of the IF-2m t cDNA is designated pTZIF2G, and the
insert contained in this plasmid is designated IF2G when referred to
below.
DNA Sequencing-All DNA sequencing was carried out using dou-
ble-stranded DNA plasmids as templates (23). Both strands of cDNA
clones were sequenced using the sequenase system (D. S. Biochemical
Corp.) or with Taq DNA polymerase in the Automatic DNA Sequencing
Facility at the University of North Carolina. Amino acid and nucleotide
sequences were analyzed using the GCG software package from the
University of Wisconsin Genetics Computer Group running on a VAX
computer.
Screening cDNA Libraries-The insert in pTZIF2G was excised,
amplified using PCR, and radioactively labeled using random hexamer
primers and the Klenow fragment of DNA polymerase I (24). Screening
cDNA libraries and the purification and sequencing of positive clones
were performed according to previously described methods (22). Three
human cDNA libraries from Stratagene were used: a (N)Joligo(dT)-
primed fetal brain library, a heart (N)Joligo(dT)-primed ZAPII cDNA
library, and an oligord'I'l-primed liver AUni-ZAP XR cDNA library.
Approximately 1 x 106 plaques from each library were screened with
32P-Iabeled IF2G DNA as a probe (22). Inserts from positive plaques
were excised in vivo from the AZAP vectors according to the manufac-
turer's suggested protocol. Cells carrying pBluescript SK- plasmids
containing IF-2m t cDNAs were identified by colony hybridization with
the IF2G probe.
Northern and Southern Analysis-A nylon membrane containing
poly(A)+ RNA from various tissues (Clontech) was used for the North-
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FIG. 1. Conserved sequences in IF-2
and cloning strategy. The primer P2F
was designed based on a sequence con-
served in prokaryotic IF-2s. Primer PIR
was based on a sequence found in yeast
IF-2 m t and in a peptide obtained from bo-
vine IF-2 m t • Primers PIF and P2R were
based on sequence information obtained
with bovine IF-2 m t • Primer PIR was used
to prepare a specific cDNA using human
liver polytA)" RNA and reverse tran-
scriptase. Two rounds of PCR were then
carried out using the indicated primers.











em analysis. The blot was hybridized using standard methods (22). A
nylon membrane containing EcoRI-digested genomic DNA from various
sources (Clontech) was used for the Southern analysis (22).
RESULTS AND DISCUSSION
Molecular Cloning of Human IF-2 m t eDNA-The overall
strategy used to obtain a cDNA clone for human liver IF-2m t
was based on two pieces of information: preliminary partial
peptide sequence data that had been obtained on bovine IF-
2m / and the conservation of certain sequences in IF-2, partic-
ularly in the G-domain. A cDNA specific for IF-2m t was pre-
pared using human liver mRNA and the reverse primer PIR
(Fig. 1). The sequence of the degenerate oligonucleotide primer
PIR was based on the peptide GGDVQ(AIV), which is located at
the end of the G-domain. This peptide sequence was obtained
from partial sequence analysis of the bovine liver IF-2 m t .
2 It is
also found in yeast IF-2 m t , and, thus, there was a strong pos-
sibility that it would be present in human IF-2m t . Following
first strand cDNA synthesis, PCR was used to specifically
amplify potential IF-2m t sequences present. A first round of
PCR was carried out using degenerate oligonucleotide primers
(PIF and PIR) both derived from peptide sequences obtained
from the bovine liver IF-2 m t (Fig. 1). A product of the expected
size (460 bp) was present among the products after the first
round of PCR amplification (data not shown).
To ensure that this band was indeed derived from the IF-2 m t
cDNA, a second round of PCR was carried out. This step was
based on the observed sequence conservation of the IF -2s from
various organisms (Fig. 1). The peptide sequences of the factors
from Escherichia coli (12), Bacillus stearothermophilus (14),
Streptococcus faecium (15), and Bacillus subtilis (13), along
with Saccharomyces cerevisiae IF -2m t (19), were analyzed using
the PILEUP program in the GCG software package. The sense
primer P2F was designed from one of these sequences, PV-
VTIMG, which marks the amino-terminal boundary of the G-
domain of prokaryotic IF -2 (Fig. 1). A second round of PCR was
carried out using a nested set of primers lying inside the first
2 M. Farwell, J. Ma, W. Burkhart, and L. Spremulli, unpublished
observations.
pair of primers (the P2F primer derived from sequences con-
served in IF -2s and P2R derived from peptide sequence infor-
mation obtained from bovine IF-2m t ) . Gel analysis indicated
that the major product corresponded well to the size predicted
to span the region between the selected primers. The product
was cloned and sequenced. The amino acid sequence deduced
from the cDNA clone shares 59% identity to the yeast IF -2m t
and 69% identity to E. coli IF-2. It exhibits over 90% identity to
the bovine IF-2 m t peptide sequences shown in Fig. 1. It has 27%
sequence identity to elF-2y but no significant homology to
either the ex or (3 subunits of elF-2. The cDNA obtained, there-
fore, most likely encodes a portion of the G-domain of human
liver IF-2m t .
The liver IF-2 m t cDNA was used to screen a human liver
oligord'I'j-primed ,\Uni-ZAP cDNA library. 16 positive clones
with inserts ranging in size from 500 to 2500 bp were purified,
and the plasmids containing the inserts were excised in vivo.
The largest clone characterized carries a 2541-bp-Iong insert
and was sequenced in both directions. This clone is derived
from a mRNA containing a 270-base pair 5'-untranslated
leader (UTL), a 2181-base pair open reading frame encoding
IF-2 m t , a 26-base pair 3' -untranslated leader, and a poly(A) tail
of over 60 residues (Fig. 2). Recently, cloning of human infant
brain-expressed sequence tags has yielded two clones contain-
ing sequences encompassing about 165 amino acids that are
homologous to bacterial IF-2s (25). These expressed sequence
tag clones are 98 -99% identical to regions in the G-domain and
near the COOH terminus ofthe human IF-2 m t cDNA identified
here. Therefore, we believe that these expressed sequenced
tags are derived from human IF-2 m t cDNAs.
Human heart and human fetal brain cDNA libraries were
also screened, and IF -2m t cDNA clones were isolated from
them. The complete nucleotide sequences of two clones with
2.5-kb inserts were obtained from the heart and fetal brain
libraries. The IF-2 m t cDNAs from heart and fetal brain share
essentially the same coding sequence and 3' -untranslated re-
gions. The heart and liver cDNA share the same 5'-untrans-
lated leader except that the heart IF -2m t cDNA has a slightly
















31 ROW R B G Ii' S SAY P v W T A Q L CAW P W P T 0 V L H G A A L S Q Y R L L V 70
211 ACU GG G GGIoCCATGGAIoATCTCAG'l''l'ATCTTCAACIoAAIoTCTAAUAGGTGGTAGAAGTATGGIoTroGIoA'1'GACTATTGAGGAACT=CAGGGCUTGG CACA 330
71 T It It B B G P WitS 0 L SST It S It It V V B V WIG K T I B B L A R A KElt H T 110
331 GATTATGTATATGAAGCTTTATTGA1I.CACTGATATTGACATAGATTCACTGGAAGCAGACTCACATTTAGATGAAGTCTGGATCAIoAGAAGTGATAACGAAGGCAGGGATGAAGTTAAIoG 450
111 0 Y V Y B ALL N T 0 I DID S L BAD S B L 0 E V W I It E V I T K A G K K L K 150
451 TGGAGTAAIoTTAA""CAGGACA"AGTC.AQll ""loA ATAAIoGATGCTGTAAGAAGGCCCCAGGCAGATCCAGCTTTATTAACCCCAAGGTCCCCAGTTGTTACTATAATGGGCCATGTTGAT 570
151 W S It L It Q 0 It V R It liI K D A V R R P Q A D PAL L T P R S P V V T I KGB V 0 190
571 CACGGGAAAACGACATTACTTGACAAAUTCGA1I.IoAACTCAAGTGGCAGGAGTGGAAACTGGAGGCATCACTCAGCACATTGGTGCCTTTCTTGTCTCTCTGCCTTCTGGGG''''AraTA 690
191 B G It TTL L 0 It Ii' R It T Q v A A VET G G I T Q BIG A Ii' L V S L PSG B It I 230
691 ACTTTTCTTGATACTCCAGC::ACATGCTGCTTTCTCAGCAATGAGAGCCAGAGGTGCTCAGGTCACTGACA'1'TGTCGTATTGG'1'TG'1'AGCTGCAGATGATGGAGTGATlOI'''AC.. ''ACTG'1'10 810
231 T Ii' LOT P G B A A Ii' S A K R A R GAO V T 0 I V V L V V A ADD G V M It Q T V 270
811 GA1I.'1'CTATTCAGCA'1'GCCAAAGA'1'GCACAGG'1'TCCTATTATCC'1''1'GCCGTAAIoTAAIo'1'GTGACAIoAGCTGAf;GCTGATCCTGAGAAAGTGAAAAIoAGAGCTGCTGGCT'1'ACGATGTGGTA 930
271 B S I Q B A It 0 A Q v P I I L A V H It COlt A BAD P B It V It K ELL loYD V V 310
931 TG'1'GAAlOA'1'TATGGAGGTGATGTTCAAGCAGTGCCTGTCTCCGCACTTACGGGCGATAATCTGAT=TTTGGCAGAAGCAACAGTTGCTCTTGCAGAAATGTTAGAATTGAAAGCAGAT 1050
311 C BOY G G 0 v Q A V P V SAL T G' 0 N L MAL A BAT V A LAB M L E L It A 0 350
1051 CCCAATGGTCCAGTGlOI''IGGA.. CAGTAATAGAGTCTTTCACAGACAAAGGAAGAGGTCTTGTTACTACAGCTATAATTCA''AGAGlOI'ACTTTAAGAAAAGGCTCTGTTCTGGTTGCTGGA 1170
351 P N G P V B G T V I B S Ii' T 0 It G R G L V TTl. I I Q R G T L R It G S V L V A G 390
1171 AAIoTGT'1'GGGCAAAAGTACGCTTAATGTTTGATGAAAIo'f<'QAU'ACAUTGATGAf;GCCTATCCCAGCATGCCAGTGGGA1I.TTACAGGCTGGAGAGACCTTCCTTCTGCAGGIoGAAGAA 1290
391 It C • A It V R L N Ii' 0 B )J G It TID BAY P S M P V G I T G W R 0 L PSI. G B E 430
1291 A'1'TCTTGAAGTAGA1I.TCTGAGCCAAGGGCACGTGAAGTTGTTGACTGGAGGAAATATGAACA..GUC ..GG..G.... AGGTCAGGAGGATCTGAAAATAATAGAAGIoAAAGCGAUGGAACAC 1410
431 I LEV E S B P R ARE V VOW R It Y B Q E Q E It G QED L It I lEE It RitE B 470
1411 AAAGAAGCACATCAGAAAGCCCGTGAGAAGTATGGCCATCTACTG=AlOAAGAGATCAATTCTACGGTTTTTAlOI''' AlOAIoA AlOAACAIoATACCCTTAAIoGCC,,".AGAlOI' .... I\GGGAA 1530
471 It It ABO It ARB It Y G B L L W It It R S I L R Ii' L E RitE Q I P L K P It E It R E 510
1531 AGAGATTCAAATGTACTTTCTGTGATTATTAAAGGTGATGTTGATGGTTCTGTTGAGGCCATTTTGAACATTATAGATACCTATGATGCTTCACACGAGTGTGAACTAGAATTAGt'ACAT 1650
511 R 0 S liI V L S V I I It G D V 0 G S V E A I L N I lOT YOlo S B B C E L E L V R 550
1651 TTTGGAGTGGGTGATATAAGTGCAAIoTGATGTTAACCTTGCTGAAACATTTGATGGTGTTATATATGGCTTTAATGTGAATGCAGGCAATGTTATCCAACAGTCAGCTGCAAAAAIoAGGA 1770
551 Ii' G V G 0 I SAN 0 V N LAB T FOG V I Y G Ii' N V NAG N V I Q Q S A A It It G 590
1771 GTAAAAATTAAIoCTTCACAAAIoTAATTTACCGTCTTGTt'GAAGATTTGCUGllGGll~TGAGCAGCAGATTACCCTGTGCTGTGGAAGAGCACCCAGTAGGTGAGGCATCTATACTAGCT 1890
591 V It I It L B It I I Y R L V E 0 L Q BEL S S R L P C A VEE B P V GEl. S I L A 630
1891 ACCTTCTCt'G'l'AAC'GAAGGGllAlOA"""'AGTTCCTGTGGCTGGCTGCAGAGTCCAlUlAGGGACAGTTAGAAAAACAIoAAAAAATTTAAIoCTAACCCGTAATGGACATGTAATTTGGAAG 1910
631 T Ii' S V T B G It It It V P V A G C R V 0 It G Q L E Ie Q It It F It L T R N G B V I W It 670
2011 GGCTCATTAACCTCAUGAAACACCATAAAlOA'l'GACATTTCAATTGTCAAAIoCGGGAATGGATTGTGGTCTCAGTTTAGATGAAGACAATATGGAATTTCAAGTGGGAGACAGAAUGTT 2130
671 G S L T SLit B BleD 0 I S I V It T G N 0 C G L S L 0 EON H B F Q v G 0 R I V 710
2131 TGTTATlOI'AlOA"""GC.AAA'l'TCAAGCCAAGACTTCTTGGGATCCAGGIoTUTAAUTTACATTAAUATGTAAIoTAACTC (A).
711 C Y BElt Q I Q A Ie T S WOp G F *
2241
727
FIG.2. Nucleotide and deduced amino acid sequences of human liver IF-2m t • Sequences in the 5' -untranslated leader are designated as
negative numbers. The nucleotide numbered +1 corresponds to the first base of the initiation codon ATG at the beginning of the longest open
reading frame. The putative polyadenylation signals are underlined, and (A)n denotes the poly(A) tail. The proposed processing site for the
mitochondrial processing endopeptidase is indicated by a solid inverted triangle.
brain IF-2m t cDNA, however, is very different from those found
in the heart and liver clones. It is possible that this difference
may have arisen from the transcription of separate genes or
may be the result of the cloning process.
Analysis of the IF-2 m t cDNA Sequence-The 5'-UTL of the
human liver IF-2m t cDNA is 270 bp in length and contains 3
ATG triplets, all of which are out of frame with respect to the
initiation codon ofIF-2m t (Fig. 2). Each of the three ATGs in the
5'-untranslated leader marks the beginning of a short up-
stream open reading frame (uORF). Between uORF1 and
uORF2, there is a T-rich segment consisting of 50% T's, The
reading frames of uORF2 and uORF3 overlap with uORF3
contained within uORF2. None of the three uORFs overlaps the
sequence coding for IF-2m t , and uORF2 terminates 31 bases
upstream from the initiation codon. According to the widely
accepted scanning model for the initiation of translation in the
eukaryotic cytoplasm, the 40 S ribosomal subunit and initia-
tion factors bind to the 5' -end of the mRNA and migrate along
the 5' -UTL until the first AUG codon in a good context is
reached. This AUG codon is usually the first AUG from the
5' -end of the mRNA. Initiation generally occurs at this position
(26). Experimental evidence indicates that uORFs strongly in-
hibit the translation of the downstream protein-coding se-
quence, presumably due to a low efficiency of ribosomal reini-
tiation at the downstream open reading frame (27-29). The
translation of the IF-2m t open reading frame may be down-
regulated by the presence of these uORFs.
The long open reading frame is 2181 residues long and en-
codes a 727-amino acid protein. The translational initiation
codon for IF-2 m t has been tentatively identified as the first
in-frame AUG of this long open reading frame. The 3' -untrans-
lated region of the cDNA is unusually short, and this 26-bp-
long sequence is 85% AlT. As shown in Fig. 2, two sequences,
ATTAAA and AATAAC, upstream from the polytA) tail resem-
ble the consensus sequence AATAAA for polyadenylation (30).
Therefore, one or both of them is probably used as a polyade-
nylation signal for the human IF -2m t gene. It has been reported
that the eIF-2f3 gene may also use ATIAAA as the signal for
polyadenylation (17).
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Human Mitochondrial Initiation Factor 2 1863
Identity to human IF-2 m , "
TABLE I
Homologies between IF-2 polypeptide sequences
B. stearothermophilus 8 66 37 37
B. subtilis 11 70 35 38
S. [aecium 10 63 35 35
E. coli 12 69 34 36
Mitochondria, S. cerevisiae 18 59 32 32
%
Amino COOH
terminus. Center' terrninusd Overall"
Species compared
a Calculated as the sum of identical residues shared at the aligned
positions between the two sequences divided by the total number of
overlapping residues (Fig. 3).
b.c.d The amino terminus is defined as the amino acid sequence of
human IF-2 m , between Met-I and Ser-I80. The Center is defined as the
residues from Pro-I81 to Asn-330 and encompasses the G-domain. The
COOH-terminus is the sequence from Leu-331 to Phe-727.
C Calculated as the length-weighted average of the amino terminus,
Center, and COOH terminus values.
on cytosolic polysomes and are subsequently imported into
mitochondria. The vast majority ofthese precursors carry ami-
no-terminal presequences, which contain the information re-
quired for their targeting to mitochondria. However, no signif-
icant sequence homology has been found in the mitochondrial
targeting sequences. In general, presequences of mitochondrial
proteins are rich in positively charged residues, lack acidic
residues, and most have a high content of hydroxylated resi-
dues (31). In addition, many of these sequences appear to be
able to form amphiphilic a helices. The first 30 amino acids of
human liver IF -2m t from the amino terminus contain a number
of basic residues, including 2 lysines, 4 arginines, and 2 hy-
droxylated amino acids. The mitochondrial targeting sequence
at the amino terminus of human IF-2 m t is predicted to form an
amphiphilic a helix between residues 1 and 15. A putative
cleavage site is predicted between Ala-29 and Leu-30 based on
the analysis of cleavage patterns in other mitochondrial import
sequences.
The predicted mature form of IF -2m t consists of 698 amino
acid residues and has a molecular weight of 77,500. Its isoelec-
tric point is calculated to be 6.6. Previous work has indicated
that bovine IF-2 m t has an apparent molecular weight of 85,000
on SDS-polyacrylamide gel electrophoresis. Thus, human and
bovine IF-2m t appear to be similar in size. Human liver IF-2 m t
is similar to prokaryotic IF-2 (except E. coli IF-2a) in size. It is
about 50 residues longer than yeast IF-2 m t , assuming that the
transit sequences are about the same length (19).
As indicated in Fig. 3 and Table I, the peptide sequence of the
mature form of human IF -2m t displays extensive homology to
the COOH-terminal two thirds of prokaryotic IF-2s. However,
it shows no significant similarity to the amino-terminal peptide
sequences of these factors. The amino-terminal peptide se-
quence (Leu-30 to Ser-180) of the mature human IF-2m t has
29% charged residues. The corresponding regions in the IF-2
of E. coli or yeast mitochondria contain approximately
26% charged residues. Using Chou-Fasman and Garnier-
Osguthorpe-Robson methods, we predict that both the human
mitochondrial factor and E. coli IF-2 have similar secondary
structures at this region (32, 33).
There is striking primary sequence homology in the G-
domain of IF-2, the central domain corresponding to residues
392-540 of E. coli IF-2a and residues 181-330 of IF-2m t • The
central domain of human IF-2 m t exhibits an average 67% iden-
tity to prokaryotic IF-2s (Table I). However, it has only 59%
identity, the lowest among those compared, to its yeast mito-
chondrial counterpart. The alternative {3 sheet/« helix second-
ary structure predicted to be present in the G-domain ofIF-2 is
retained in the central domain of human IF-2 m t (33). The
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FIG. 4. Northern analys is o f the exp ression of IF. 2m , mRNA in
diffe rent h u man t issues.
si milarity between human IF-2 m , a nd other IF-2 s decreases
remarkably at the eOOH terminus, the region th ough t to be
the t R A binding domain. As shown in Tabl e I, human IF-2 m ,
has an average of 35% identical resid ues with othe r IF-2 s
wit hin this region. In contrast to othe r IF-2s, th e region from
Asp-429 to Glu-5 12 in the e OOH terminu s of human IF-2 m ,
has the highest surface probability in th e whole molecule. Over
50'71- of the a mino acid residues wit hin th is region are charged.
It a lso has a n extra 37 amino acid residues not found in an y
prokaryotic IF-2 . These addit iona l amino acids (Fig. 3) are
clus te red primarily in three closely spaced sections near th e
beginning of the e OOH-te rmina l ha lf of th e prot ein . Two of
th ese regions are also observ ed in yeas t IF-2 m " In general,
human IF-2 m , shows a n overall 36% seque nce iden tity to IF-2
from prok a ryotes a nd yeast mito chondria. Th e obse rvations
summarized above suggest that th e G-domain ofIF-2 has been
high ly conserved during evolut ion whil e oth er region s of th e
molecule have been allowed to diverge to a grea te r exte nt.
A bunda nce of IF-2m t mRNA in Different Human Tissues-
The abundance of the IF-2 m , tran script in va rious human tis-
sues was determined by Northern blotting using th e IF2G DNA
(the G-domain) as a probe. As shown in Fig. 4, transcripts of
IF-2m , migra tin g at approxima te ly 2.5 kb were det ected in all of
the t issues exa mined. Th e est imated size of th e IF-2 m , mRNA
is very close to the length of the eDNA cloned (2541 bpi. Heart,
liver, skeletal mu scle, and kidney all had relatively abundant
level of the IF-2 m , t ra nscript, with ske leta l mu scle ha ving th e
highest abunda nce am ong the tissu es tested. Lower amounts of
the IF-2m ! mRNA were detected in brain , placenta , lun g, and
pan creas. The IF-2m , message levels in these tiss ues are esti-
mated to be 20- 50-fold lower tha n in skeleta l mu scle. As ex-
pected , the IF-2m , gene is expressed to some exte nt in all of th e
t iss ues tested with higher levels of expression observed in
specia lized tissu es kn own to have a high demand for energy.
In addit ion to the major IF-2 m ! mRNA observed at 2.5 kb ,
two other bands of a pproximately 3.5 and 1.5 kb, respectively,
were observed on the Northern blot (Fig. 4). These ba nds are
present a t about 5% of the inte ns ity of the prominent 2.5-kb
tra nscript and may represen t signals from a related gene.
FIG. 5. Sou ther n a nalysis of the p r ese n ce o f seq uen ces r elated
to IF-2m • in different species.
Alternatively, th ey could arise from a precursor and a degra-
dation product, respectively, of th e IF-2m ! mRNA.
Conservation of the IF-2,,1I Sequence in Different Sp ecies-
Sinc e th e G-domain ofIF-2 a ppea rs to be highly conserv ed, we
have used th e human IF2G DNA as a probe for sequences
homologous to IF-2m , in the genomic DNAs of a wide range of
species (Fig. 5). Between one and three restriction fragments of
genomic DNA from eukaryotes as widely divergent as yea st
an d human hybridize wit h th is probe a t high stringency. This
observation confirms th e general idea that IF-2m , is highly
conserv ed thro ughout the euka ryotic kingdom, at least in the
regio n encoding the G-domai n.
Aclmowledgmenls-We th ank Dr. Mary Farw ell , Jianhong Ma, and
Will Burkh art for provid ing information on peptide sequences of bovine
IF-2m . ,
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